Under the joint-organization of PCR, CIT (China Interventional Therapeutics), and West China Hospital of Sichuan University, the first edition of “PCR-CIT China Chengdu Valves” (PCCV) is scheduled from 4th - 6th November, 2016 in Chengdu, China. It will be organized based on the successful experience of PCR London Valves, under the theme of Transcatheter Aortic Valve Implantation (TAVI). This conference will focus on basic skill training through hands-on practice, live demonstration, academic lectures and case-based discussions. The PCCV course will help improve the ability of doctors in China and the Asia-Pacific region to use this technology and hopefully promote its development for the benefits of the patients.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved